Cargando…
AB003. Benefits of proton radiotherapy in thymic epithelial tumors using the model-based approach
BACKGROUND: Radiotherapy (RT) for thymic epithelial tumors (TET) is indicated postoperatively for advanced/aggressive disease or incomplete resection, or as primary treatment in inoperable patients. In selected patients, proton therapy spares better normal tissues compared to standard photon treatme...
Autores principales: | Peeters, Stephanie T. H., Kneepkens, Esther, Marcuse, Florit, Zhang, Xin, Hochstenbag, Monique, Maessen, Jos, Ruysscher, Dirk De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792829/ http://dx.doi.org/10.21037/med-22-ab003 |
Ejemplares similares
-
AB004. Radiotherapy for thymic epithelial tumors: what is the optimal dose?—a systematic review
por: Angrisani, Antonio, et al.
Publicado: (2022) -
“Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.”
por: Angrisani, A., et al.
Publicado: (2022) -
The association between anti‐acetylcholine receptor antibody level and clinical improvement in myasthenia gravis
por: Marcuse, Florit, et al.
Publicado: (2022) -
Expression of pRb and p16INK4 in human thymic epithelial tumors in relation to the presence of human polyomavirus 7
por: Keijzers, Marlies, et al.
Publicado: (2015) -
Symptomatic mediastinal mass in a 32-year-old male
por: Marcuse, Florit, et al.
Publicado: (2021)